InsiderTrades

Form 4 for DNA Ginkgo Bioworks Holdings, Inc.

Accepted 2025-12-16 00:00:00 ET · period of report 2025-12-12 · accession 0001628280-25-057441 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2025-12-16 2025-12-12 DNA Coen Steven P. See remarks M - OptEx — +1,486 7,912 +23% —
D 2025-12-16 2025-12-15 DNA Coen Steven P. See remarks S - Sale+OE $8.89 -736 7,488 -9% -$6,543
DM 2025-12-16 2025-12-12 DNA Coen Steven P. See remarks M - OptEx — -1,486 9,992 -13% —

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Class A Common Stock 2025-12-12 M A 312 — 8,224 D — — (F1) Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.
2 Common Class A Common Stock 2025-12-15 S D 736 $8.89 7,488 D — —
3 Common Class A Common Stock 2025-12-12 M A 1,174 — 7,912 D — — (F1) Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.
4 Derivative Restricted Stock Units 2025-12-12 M D 312 — 4,223 D — · — to — 312 Class A Common Stock (F1) Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. (F4) The RSUs vest as follows: 2/48ths of the underlying shares vested on May 1, 2024, then 46 equal monthly installments thereafter.
5 Derivative Restricted Stock Units 2025-12-12 M D 1,174 — 9,992 D — · — to — 1,174 Class A Common Stock (F1) Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. (F3) The RSUs vest as follows: 25% of the underlying shares vested on May 1, 2024, then 36 equal monthly installments thereafter.